BC-backed VetPartners acquires Hyperthyroid Cat Centre

Founder Andrew Bodey will continue as clinical director of the company, while all employees will be staying on.

BC acquired VetPartners from Ares Management, Credit Group and August Equity for a valuation of approximately £700m in 2018. It drew equity from its 10th-generation fund, which closed on €7bn in 2018.

Since then, the company has made several acquisitions, including Clyde Veterinary and Abbey Veterinary.

Company
Hyperthyroid Cat Centre treats feline hyperthyroidism, a condition that causes weight loss, increased appetite, restlessness and heart disease. Its team has managed 2,000 hyperthyroid cats, using radio-iodine treatment. It operates from a single site in Wetherby and was founded in 2013.

People
VetPartners – Jo Malone (CEO).

Advisers
Acquirer – Lupton Fawcett, Giles Clegg (legal).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Portfolio management
• UK / Ireland
• Consumer
• United Kingdom
• BC Partners
• Build-up
• Buy-and-build